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We report the first chemical probe that enables bioorthogonal 
chemical tagging of post-translationally cholesterylated proteins 
with an azide in live cells. Our approach enables rapid 
fluorescence and affinity labelling of protein cholesterylation, as 10 
exemplified by multi-label detection of Sonic hedgehog 
cholesterylation in multiple cell lines, and multiplexed 
fluorescence detection of cholesterylation and palmitoylation. 
These probes are expected to be of great utility for the 
identification of novel cholesterylated proteins, and for exploring 15 
the role of protein cholesterylation in living systems, for example 
in development and cancer. 
Post-translational modification (PTM) of proteins is an 
essential process in all cells, and plays a key role in signal 
transduction and protein trafficking.1 An important example is 20 
the mammalian Hedgehog (Hh) protein family; these potent 
morphogens are essential in the development and patterning of 
organs and other essential processes,2 and are subject to a 
complex series of PTMs, as exemplified by Sonic hedgehog 
(Shh). During maturation in the endoplasmic reticulum (ER) 25 
Shh undergoes intein-like autocleavage of its C-terminal 
domain (Fig. 1) accompanied by C-terminal cholesterylation,3 
and N-terminal palmitoylation by the enzyme Hedgehog acyl 
transferase (Hhat).4 Both PTMs play an important but 
complex role in subsequent Shh secretion and signalling.5  30 
Fig. 1 Post-translational processing of Sonic Hedgehog (Shh) protein in 
the ER. Cleavage of the signal peptide from Shh precursor protein (A) is 
followed by palmitoylation at the N-terminus (B) by the membrane 
integral acyl transferase Hhat and C-terminal autocleavage-
cholesterylation to form a cholesteryl ester at the C-terminal acid (C), 35 
rendering fully processed N-terminal domain (Shh-N). 
 Mis-regulated Shh signalling promotes the formation and 
progression of certain cancers, attracting recent interest in 
targeting Shh signalling or lipidation for anti-cancer 
chemotherapy.6, 7 However, the mechanisms by which the 40 
lipid motifs of Shh contribute to signalling remain poorly 
understood, and appear to vary across different signalling 
contexts, timescales and distances.8 It has also been suggested 
that protein cholesterylation is not restricted to the Hedgehog 
family,5 but to date the tools have not been available to 45 
explore this hypothesis. Here we report the design and 
application of the first chemical probe that enables 
bioorthogonal tagging of cholesterylated proteins in live cells. 
We also describe simultaneous bioorthogonal tagging of both 
post-translational lipidations of Shh using a combination of 50 
palmitate and cholesterol analogues, and their detection by 
multiplexed in-gel fluorescence.  
Scheme 1 i) Imidazole, TBS-Cl, DMF, 82%; ii) NaBH4, THF, MeOH, 
83%; iii) NaH, THF, 0 °C, then N,N-Dimethylacrylamide, 54%; iv) 
LiBHEt3, THF, 0 °C, 89%; v) MsCl, Et3N, DCM, 0 °C–rt; vi) NaN3, 55 
DMF, 90 °C, 25% over two steps; vii) TBAF, THF, 90% 
 Despite the importance of palmitoylation and 
cholesterylation in various signalling activities of Shh, 
relatively little is known about the tolerance of these 
processes for modifications in the two lipid donors. Whilst 60 
cholesterol analogues are used for labelling cholesterol-rich 
membrane microdomains and azide functionalized steroids 
have been used as synthetic intermediates,9 to date none have 
been reported as substrates for protein cholesterylation. We 
reasoned that modifications distal to the 3-OH nucleophile 65 
involved in the cholesterylation reaction would prove least 
disruptive to processing, and envisaged a probe bearing an 
azide chemical tag in the C22–26 chain, commencing from the 
prohormone pregnenolone (1, Scheme 1).  
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Fig. 2 Trifunctional capture reagents comprising an alkyne (9) or azide 
(10) tag, TAMRA fluorophore and biotin labels; palmitic acid (11) and 
alkynyl-palmitate analogue (12); bifunctional capture reagent ‘alkynyl-
fluorescein’ (13). 
 The intermediate alcohol 3 proved particularly difficult to 5 
alkylate.10 However, addition to N,N-dimethylacrylamide 
under optimised conditions provided the unstable intermediate 
4, which was readily reduced to the alcohol 5 using Super-
Hydride® (LiEt3BH) in excellent yield. The high reactivity of 
this reagent permits reduction to be performed at 0 °C in order 10 
to avoid facile -elimination that occurs at higher 
temperatures. 5 was subsequently converted via a short 
reaction sequence into target probe 8 bearing an azide tag. 
    To explore the potential of 8 as a substrate for 
cholesterylation, HEK293a cells transiently transfected to 15 
overexpress Shh were treated with different final 
concentrations of 8 for 16 hours. Cell lysates were then 
subjected to copper-catalysed azide–alkyne cycloaddition 
(CuAAC)11, 12 to trifunctional capture reagent 9 (Fig. 2),13, 14 
introducing dual labels for affinity purification and 20 
fluorescence visualisation of ligated targets. These labelled 
samples were then probed by in-gel fluorescence and α-Shh 
Western blot. In lysates from cells treated with 8, labelled 
Shh-N (‘Shh-N*’) was readily visualised as a strongly 
fluorescent band (red arrow, Fig. 3A), with labelling intensity 25 
dependent on the concentration of 8 used in the feeding step. 
α-Shh Western blot (Fig. 3B) revealed a small band shift to 
higher apparent molecular weight following ligation to 9 (Fig. 
3B), consistent with an increase in mass. Interestingly, a range 
of proteins other than Shh-N are also tagged by 8, with 30 
labelling intensity increasing in proportion to the 
concentration of the probe (blue arrows, Fig. 3A). This 
observation is consistent with the presence of multiple 
cholesterylated proteins,5 and suggests the potential of 8 as a 
general tool for exploring cholesterylation. 35 
 From these data it appears that 8 is a good substrate for the 
Shh C-terminal intein-like domain, particularly in view of the 
fact that 8 has to be transported into cells and into the ER 
where Shh self-processing occurs,8 and furthermore is in 
competition with endogenous cholesterol for binding Pre-Shh 40 
inside cells. The degree of Pre-Shh processing also appears to 
be enhanced with increasing concentration of 8. At the highest 
concentration tested (100 M) 8 caused some rounding of 
cells whilst lower concentrations had no observable side-
effects, and thus 50 M 8 was selected for further 45 
experiments. Taking advantage of the dual label in 9, pull-
down on streptavidin-coated magnetic beads permitted highly 
specific isolation of Shh-N* from cells fed with 8 (Fig. 3C). 
Unprocessed Shh (Pre-Shh, Fig. 3) is neither labelled nor 
affinity purified under these conditions, showing that labelling 50 
is dependent on self-processing as for native cholesterylation. 
This observation is consistent with specific mechanism-based 
labelling by 8, and with studies on radiolabeling of Shh-N 
with tritiated cholesterol.5  
 Shh is known to be upregulated in certain cancers including 55 
lung adenocarcinoma15 and pancreatic carcinoma,16 and mis-
regulated Shh signalling in vivo contributes to cancer cell 
proliferation and maintaining the tumour’s physiological 
niche. To investigate the utility of 8 as a probe for 
Fig. 3 Tagging cholesterylation in live cells with 8. A-C) HEK293a cells transfected with Shh were fed with 8 (++: 100 M; +: 50 M; –: DMSO vehicle 60 
only) for 16 h at the concentrations indicated, and lysates captured with 9 (see ESI for further details). Proteins were separated by SDS-PAGE and 
observed by A) in-gel fluorescence or B) -Shh Western blot. Pre-Shh: unprocessed Shh precursor; Shh-N: processed but untagged Shh protein; Shh-N*: 
Shh tagged with 8 and labelled by 9. ↔: fluorescent Shh-N* band; ↔: other proteins tagged by 8. C) Labelled lysates affinity purified on streptavidin-
coated magnetic beads; protein remaining in supernatant (Supnt.) or retained on beads (Beads) after pull-down, analysed by -Shh Western blot. Shh-N* 
is pulled down specifically in cells fed with 8. D) Wild-type (non-transfected) PANC1 and A549 cancer cell lines or HEK293a cells were fed with 8, 65 
captured with 9, and visualised as in (A). E) HEK293a cells transfected with Shh were fed with 8 and/or 12 as indicated; all samples were subjected to 
CuAAC with 10, protein precipitation (to remove excess 10), and then with 13; in-gel fluorescence imaging at TAMRA and fluorescein wavelengths.  
 
cholesterylation of upregulated Shh, A549 (human lung 
adenocarcinoma), PANC1 (human pancreatic carcinoma) and 
wild-type HEK293a (control) cells were fed, and the lysates 
labelled with 9 and affinity enriched. In-gel fluorescence 
provides a direct readout for Shh-N* in the cancer cells (Fig. 5 
3D). Notably, fluorescence detection of Shh cholesterylation 
tagged with 8 is complete in seconds, whereas detection with 
3H radiolabeled cholesterol in these lines is orders of 
magnitude slower, requiring days or even weeks of exposure. 
 Shh is also palmitoylated in vivo by Hhat, and we 10 
hypothesised that Shh could be tagged using a chemical probe 
for palmitoylation, potentially enabling orthogonal 
multiplexed detection of both lipidation events in the same 
experiment. Fatty acid probes have been used to label acylated 
proteins in living systems,1, 17-20 however this has not 15 
previously been reported for Shh and so we determined the 
suitability of heptadec-16-ynoic acid 12 (Fig. 2), an alkyne-
tagged analogue of palmitic acid 11, as an Hhat substrate in 
live cells. 12 was fed to HEK293a cells overexpressing Shh 
and captured from cell lysates using bioorthogonal ligation to 20 
azide-TAMRA-biotin capture reagent 10. 12 was found to be 
incorporated into Shh-N with reasonable efficiency at 100 M 
(ESI, Fig. S1). Encouraged by this result, we investigated 
simultaneous labelling of Shh cholesterylation and 
palmitoylation in these cells. HEK293a cells overexpressing 25 
Shh were fed with 8, 12 or 8+12 (or DMSO vehicle), and 
sequential CuAAC chemistry was performed on each cell 
lysate in turn with 10, followed by 13. 10 introduces a dual 
TAMRA/Biotin label on palmitoylated proteins, whilst 13 
labels cholesterylated proteins with fluorescein; protein 30 
precipitation between reactions served to remove excess 10. 
Shh tagged by 8 and/or 12 was readily observable by two-
colour in-gel fluorescence detection (Fig. 3E), with no 
detectable background labelling of Shh by mismatched 
capture reagents. No adverse effects on cell proliferation were 35 
observed at the probe concentrations used. 
 We have reported here the design and synthesis of the first 
chemical probe for bioorthogonal tagging of protein 
cholesterylation. This tagging system enables multi-label 
detection of cholesterylated Shh using a multifunctional 40 
capture reagent 9, providing handles suitable for in-gel 
fluorescence and affinity purification. The combination of 8 
and 9 provides very rapid detection of Shh cholesterylation by 
in-gel fluorescence in a range of cell lines, avoiding time 
consuming and expensive use of hazardous ionising radiation. 45 
Notably, 8 tags a number of protein bands in addition to Shh, 
suggesting that with further optimisation 8 or similar 
analogues may permit de novo chemical proteomic discovery 
of new cholesterylated proteins in living systems, by analogy 
with probes for other PTMs.19 Further, we have demonstrated 50 
multiplexed tagging of Shh cholesterylation and 
palmitoylation in live cells, one of the first examples of 
orthogonal tagging of multiple PTMs in a living system.21 We 
anticipate that the tools reported here will facilitate 
exploration of the interdependence and substrate specificity of 55 
these modifications, and their roles in cancer and 
development. Multiplexed fluorescence detection also opens 
up a range of potential future applications, including two-
colour imaging by fluorescence microscopy, and screening for 
lipidation inhibitors in cells. We will report on our on-going 60 
studies in these areas in due course. 
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